Development of a novel treatment based on PKMYT1 inhibition for cisplatin-resistant bladder cancer with miR-424-5p-dependent cyclin E1 amplification.

Autor: Fukumoto, Wataru1 (AUTHOR), Okamura, Shunsuke1 (AUTHOR), Tamai, Motoki1 (AUTHOR), Arima, Junya1 (AUTHOR), Kawahara, Ichiro1 (AUTHOR), Fukuda, Ikumi1 (AUTHOR), Mitsuke, Akihiko1 (AUTHOR), Sakaguchi, Takashi1 (AUTHOR), Sugita, Satoshi1 (AUTHOR), Matsushita, Ryosuke1 (AUTHOR), Tatarano, Shuichi1 (AUTHOR), Yamada, Yasutoshi1 (AUTHOR), Nakagawa, Masayuki1 (AUTHOR), Enokida, Hideki1 (AUTHOR), Yoshino, Hirofumi1 (AUTHOR) hyoshino@m3.kufm.kagoshima-u.ac.jp
Zdroj: BMC Cancer. 10/29/2024, Vol. 24 Issue 1, p1-10. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje